An Indian founder, who asked not to be named to avoid potential repercussions, told TechCrunch they had stopped seeing new user sign-ups from India over the past two to three days. A technology consultant working with local startups, who spoke on condition of anonymity, said they were unable to reliably access Supabase for both development and production purposes.
FT Digital Edition: our digitised print edition
，详情可参考搜狗输入法2026
“工艺皮”贴上陈皮标签以假乱真
随着减重药巨头诺和诺德重磅GLP-1类药物司美格鲁肽在中国的核心分子专利即将于3月到期，一大批中国本土的司美格鲁肽仿制药正在获批路上。据公开信息，目前国内市场上包括九源基因、丽珠集团、华东医药、齐鲁制药、正大天晴在内的十多家本土制药公司的司美格鲁肽仿制药有望在不久的将来上市，还有十余款处于三期临床，一场价格大战即将席卷。一位内分泌专家表示，随着更多仿制药的上市，减重药很快就会迎来“白菜价”时代。（第一财经）。heLLoword翻译官方下载对此有专业解读
Visit Exploding Topics From Here
Конфликт между Ираном и Израилем обостряется с новой силой.Какое оружие есть у сторон и кто может победить в этой схватке?17 июня 2025。im钱包官方下载对此有专业解读